APDN Subsidiary, LineaRx, Inc., Sign Licensing Agreement with LifeSensors
January 13th, 2020
APDN Subsidiary, LineaRx, Inc., Sign Licensing Agreement with LifeSensors
January 13th, 2020
Applied DNA to Hold Investment Community Meetings During the JP Morgan 38th Annual Healthcare Conference and Present at the Biotech Showcase 2020
January 10th, 2020
Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences
December 23rd, 2019
APDN to Report Year End, FQ4’19 Q4 Financial Results
December 12th, 2019
Applied DNA and Old Port Oil to Conduct First Pilot to Tag CBD Oil
December 11th, 2019
Applied DNA Sciences and Reliance Industries Sign MOU to Incorporate CertainT Forensic Traceability into R|Elan Fabric and Recron GreenGold® Recycled Polyester Fiber and Filament
December 10th, 2019
Applied DNA Schedules Fiscal 2019 Fourth Quarter Financial Results Conference Call for Thursday, December 12, 2019 at 4:30 PM ET
December 5th, 2019
LineaRx Signs Agreement with TYME Technologies for Functional ICTC Assay Services in Pancreatic Cancer Trial
November 26th, 2019
Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards
November 25th, 2019

Our new ticker symbol is ‘BNBX’. Learn more here.